We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+7.83%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$853M
AUM Growth
+$41.2M
Cap. Flow
-$4.27M
Cap. Flow %
-0.5%
Top 10 Hldgs %
45.97%
Holding
2,993
New
166
Increased
1,040
Reduced
961
Closed
220

Sector Composition

Rank Sector Weight
1 Financials 17.04%
2 Technology 13.3%
3 Healthcare 7.37%
4 Industrials 3.43%
5 Consumer Staples 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCPT icon
1801
Four Corners Property Trust
FCPT
$2.75B
$5.64K ﹤0.01%
210
+48
+30% +$1.32K
LKFT
1802
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
$5.64K ﹤0.01%
146
+13
+10% +$534
J icon
1803
Jacobs Solutions
J
$17B
$5.64K ﹤0.01%
58
-23
-28% -$2.29K
XRN
1804
Chiron Real Estate Inc
XRN
$477M
$5.63K ﹤0.01%
124
-22
-15% -$1.11K
SPMD icon
1805
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.9B
$5.62K ﹤0.01%
128
ASAI
1806
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
$5.62K ﹤0.01%
365
+110
+43% +$1.94K
PRMW
1807
DELISTED
Primo Water Corporation
PRMW
$5.6K ﹤0.01%
365
RWT
1808
Redwood Trust
RWT
$594M
$5.6K ﹤0.01%
831
-26
-3% -$195
NSP icon
1809
Insperity
NSP
$2.01B
$5.59K ﹤0.01%
46
+3
+7% +$351
SKYW icon
1810
Skywest
SKYW
$4.34B
$5.59K ﹤0.01%
252
+171
+211% +$3.34K
NOG icon
1811
Northern Oil and Gas
NOG
$2.35B
$5.58K ﹤0.01%
184
+61
+50% +$1.9K
WDC icon
1812
Western Digital
WDC
$150B
$5.54K ﹤0.01%
194
+116
+149% +$3.4K
PFC
1813
DELISTED
Premier Financial Corp. Common Stock
PFC
$5.51K ﹤0.01%
266
+62
+30% +$1.51K
SRPT icon
1814
Sarepta Therapeutics
SRPT
$1.77B
$5.51K ﹤0.01%
40
+12
+43% +$1.56K
SLACU
1815
DELISTED
Social Leverage Acquisition Corp I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant
SLACU
$5.51K ﹤0.01%
550
DENN
1816
DELISTED
Denny's
DENN
$5.47K ﹤0.01%
490
-28
-5% -$326
BRO icon
1817
Brown & Brown
BRO
$23.9B
$5.46K ﹤0.01%
95
+31
+48% +$1.78K
EMBC icon
1818
Embecta
EMBC
$262M
$5.46K ﹤0.01%
194
-24
-11% -$681
ERAS icon
1819
Erasca
ERAS
$6.39B
$5.42K ﹤0.01%
+1,802
New +$6.55K
XLU icon
1820
State Street Utilities Select Sector SPDR ETF
XLU
$22.7B
$5.42K ﹤0.01%
+160
New +$5.42K
INSM icon
1821
Insmed
INSM
$28.6B
$5.41K ﹤0.01%
317
-201
-39% -$3.9K
POST icon
1822
Post Holdings
POST
$3.57B
$5.39K ﹤0.01%
60
CHE icon
1823
Chemed
CHE
$7.22B
$5.38K ﹤0.01%
10
+8
+400% +$4.08K
AEL
1824
DELISTED
American Equity Investment Life Holding Company
AEL
$5.36K ﹤0.01%
147
-156
-51% -$6.63K
BHF icon
1825
Brighthouse Financial
BHF
$3.5B
$5.34K ﹤0.01%
121
+66
+120% +$3.47K

Similar funds

Lindbrook Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Lindbrook Capital held 2,993 positions worth $853M, up 5.1% from $812M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital's Q1 2023 filing shows 166 new, 1,040 increased, 961 reduced and 220 closed positions. Its largest new stake was Hess Midstream: 4,984 shares worth $144K. The largest sale was Oramed Pharmaceuticals, an estimated $4.61M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

  • Lindbrook Capital's largest Q1 2023 buy was Hess Midstream: 4,984 shares worth $144K.
  • Lindbrook Capital added most to Vanguard Total International Stock ETF in Q1 2023, an estimated $12.7M increase.
  • Lindbrook Capital's biggest Q1 2023 reduction was Agenus, cutting an estimated $2.89M.
  • Lindbrook Capital fully exited Oramed Pharmaceuticals in Q1 2023, selling an estimated $4.61M.
  • Lindbrook Capital's ten largest holdings make up 46% of its $853M portfolio in Q1 2023.
  • Lindbrook Capital opened 166 new positions and closed 220 in Q1 2023.
  • Lindbrook Capital's portfolio value rose 5.1% quarter-over-quarter to $853M.

Based on Lindbrook Capital's 13F filing for Q1 2023, filed 26 Apr 2023.